Wiedemann-Rautenstrauch syndrome, also known as neonatal progeroid syndrome, is a rare genetic condition that affects infants. It is characterized by premature aging, abnormal growth, and developmental delay. The syndrome was first described in 1979 by Wiedemann and Rautenstrauch, and since then, more than 30 cases have been reported in the scientific literature.

Genetic testing has identified mutations in several genes that are associated with Wiedemann-Rautenstrauch syndrome. These genes are involved in the production of proteins that play a role in the synthesis and processing of DNA, including DNA polymerase. Additional research is needed to fully understand the causes of this condition.

Due to the rarity of Wiedemann-Rautenstrauch syndrome, there are limited resources and support available for affected individuals and their families. However, there are advocacy groups and organizations that provide information and support to those affected by rare diseases, including Wiedemann-Rautenstrauch syndrome. These resources can provide valuable information about the condition and connect individuals and families with others who are dealing with similar challenges.

In this article, we will explore the frequency, inheritance patterns, associated features, and expected outcomes of Wiedemann-Rautenstrauch syndrome. We will also provide references to scientific articles and genetic resources that contain more detailed information about the condition. By learning more about Wiedemann-Rautenstrauch syndrome, we can better support affected individuals and work towards improved understanding and management of this rare genetic condition.

References:

1. Wiedemann HR, Rautenstrauch T. Neonatal progeroid syndrome. Eur J Pediatr. 1979;130(2):83-87. doi:10.1007/BF00441698

2. Nickerson DA, et al. Genetics, disease prevention and treatment, and public health: National Academies Press (US); 1994. Genetic testing in the neonatal period. Available from: https://www.ncbi.nlm.nih.gov/books/NBK230677/

Inflated pharmaceutical prices are another huge factor in the steep cost of healthcare. Americans spend an average of $858 per person on prescription drugs, according to Vox. That’s about twice as much as people in Australia spend on prescriptions. It’s three times the amount paid by people in The Netherlands.

3. Wollnik B. Genetics of human osteogenesis imperfecta. Clin Genet. 2004;65(6):457-467. doi:10.1111/j.1399-0004.2004.00300.x

4. OMIM Entry – #264090 – Wiedemann-Rautenstrauch syndrome. Available from: https://www.omim.org/entry/264090

Frequency

Wiedemann-Rautenstrauch syndrome (WRS) is an extremely rare genetic condition that develops in neonatal infants. The exact frequency of WRS is not well understood, as it is a highly uncommon disorder. Only a limited number of cases have been reported in the scientific literature.

WRS is considered an autosomal recessive disorder, meaning that both parents must carry a copy of the abnormal gene in order for a child to inherit the condition. The genes responsible for WRS have been identified and cataloged in the OMIM database.

  • The gene Wollnik (-), which codes for a polymerase used in DNA replication
  • The gene genes, which are involved in the production of proteins associated with normal growth and development

Due to its rarity, WRS is often not the first condition that healthcare professionals consider during diagnosis. Genetic testing can provide support to confirm the presence of WRS.

Additional information about WRS can be found in various resources, including advocacy organizations that provide support to individuals and families affected by this condition.

Pubmed is a valuable source for scientific articles and references about WRS. It is essential to synthesize information from these resources to learn more about the expected frequency, causes, and other associated conditions with WRS.

Causes

The exact causes of Wiedemann-Rautenstrauch syndrome are not yet fully understood. However, researchers believe that a combination of genetic and environmental factors contribute to the development of this rare condition.

Genetic mutations: Wiedemann-Rautenstrauch syndrome is thought to be caused by mutations in certain genes. According to scientific articles published on PubMed and OMIM, mutations in the POLR1C gene and the POLR3A gene have been associated with this condition. The POLR1C gene provides instructions for making a protein called RNA polymerase, while the POLR3A gene provides instructions for making another protein called RNA polymerase III. Mutations in these genes may interfere with the normal production of these proteins, leading to the abnormalities observed in individuals with Wiedemann-Rautenstrauch syndrome.

Inheritance: Wiedemann-Rautenstrauch syndrome is inherited in an autosomal recessive manner, which means that affected individuals inherit two mutated copies of the responsible gene, one from each parent. Parents who carry one copy of the mutated gene are usually unaffected but have a 25% chance of passing on the condition to each of their children.

Other causes: While genetic mutations are the primary cause of Wiedemann-Rautenstrauch syndrome, other factors may also contribute to the development of this condition. Environmental factors and interactions with other genes may play a role in modulating the severity and outcome of the syndrome, but more research is needed to fully understand these additional influences.

References:

Learn more about the gene associated with Wiedemann-Rautenstrauch syndrome

Wiedemann-Rautenstrauch syndrome is a rare genetic condition that affects infants shortly after birth. It is caused by mutations in the POLR3A gene, which encodes for a subunit of RNA polymerase III. This gene is involved in the production of various types of RNA molecules, including transfer RNA (tRNA) and ribosomal RNA (rRNA).

See also  Crouzon syndrome

The POLR3A gene is located on chromosome 10q22.3-23.1 and is responsible for synthesizing proteins that are essential for normal cellular function. Mutations in this gene lead to the abnormal production of these proteins, which can result in the development of Wiedemann-Rautenstrauch syndrome.

Although the exact frequency of mutations in the POLR3A gene is unknown, they have been found in patients with Wiedemann-Rautenstrauch syndrome from various ethnic backgrounds. The syndrome is thought to have an autosomal recessive pattern of inheritance, meaning that both copies of the gene must be mutated for the condition to occur.

For patients and their families, it is important to seek support and information about this rare condition. There are various advocacy organizations and online resources where individuals can learn more about Wiedemann-Rautenstrauch syndrome and connect with other families facing similar challenges.

Additional scientific articles and resources can also be found on databases such as OMIM (Online Mendelian Inheritance in Man) and PubMed, which provide information on the genetic basis and clinical features of this condition.

Genetic testing can be done to confirm a diagnosis of Wiedemann-Rautenstrauch syndrome. This involves analyzing the POLR3A gene for any mutations or abnormalities. The results of this testing can help doctors develop appropriate treatment plans and provide guidance to families.

References:

  • Wollnik, B., et al. (1997). Mutations in the gene encoding the RNA polymerase III subunit hRPC62 cause a syndromic form of tRNA transcription deficiency. Nature Genetics, 17(2): 111-113.
  • Polymorphism and mutation databases:
    • Genetic Testing Registry, POLR3A gene
    • OMIM, POLR3A gene
  • Nickerson, DA., et al. (2016). Recommendations for the validation of next-generation sequencing-based oncology panels: a Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists. The Journal of Molecular Diagnostics, 18(3): 325-352.

Inheritance

The Wiedemann-Rautenstrauch syndrome is a rare genetic condition with autosomal recessive inheritance. This means that both copies of the gene associated with the syndrome must be abnormal in order for an individual to develop the condition.

The genetic information for the Wiedemann-Rautenstrauch syndrome is currently synthesized from the scientific research conducted by Wollnik et al. While the exact genes associated with the condition are yet to be identified, the abnormal gene or genes are thought to cause abnormal protein synthesis, which leads to the characteristic features of the syndrome.

Due to the rarity of the syndrome, there is limited information available about the frequency of inheritance. However, the syndrome has been reported in infants from various ethnic backgrounds.

Additional information about the genetic factors contributing to the Wiedemann-Rautenstrauch syndrome can be found in the Online Mendelian Inheritance in Man (OMIM) catalog, a comprehensive resource for genetic diseases.

Diagnosis of the syndrome can be confirmed through genetic testing, which can identify the specific genes associated with the condition. Genetic testing can also be helpful in ruling out other genetic disorders with similar features.

References to articles and resources about the Wiedemann-Rautenstrauch syndrome and related genetic studies can be found on PubMed, the online database of scientific literature.

The Wiedemann-Rautenstrauch syndrome is often associated with neonatal-onset conditions and abnormal growth patterns. The exact causes of the syndrome are still being researched.

For more information and support about the Wiedemann-Rautenstrauch syndrome, patients and their families can reach out to advocacy groups or contact the Center for Rare Genetic Disorders.

Genetic Inheritance of Wiedemann-Rautenstrauch Syndrome
Inheritance Pattern Description
Autosomal Recessive Both copies of the gene associated with the syndrome must be abnormal for an individual to develop the condition.

Other Names for This Condition

Wiedemann-Rautenstrauch syndrome has several other names, including:

  • Neonatal progeroid syndrome
  • Progeroid syndrome, neonatal
  • WRS
  • Wiedemann-Rautenstrauch-Theakston syndrome
  • Wiedemann-Rautenstrauch syndrome, neonatal
  • WRNSTR

These alternative names may be used by healthcare professionals, advocacy groups, and support organizations to refer to the condition in different contexts.

For a more comprehensive list of alternative names and synonyms, you may consult the Genetic and Rare Diseases Information Center (GARD) Catalog of Genetic Diseases or the Online Mendelian Inheritance in Man (OMIM) database.

Additionally, the scientific literature may provide articles on Wiedemann-Rautenstrauch syndrome using different names. For more information about this condition, you can search for related articles on PubMed.

Additional Information Resources

The following resources provide additional information about Wiedemann-Rautenstrauch syndrome:

  • Genetic Home Reference: A guide to understanding genetic conditions. This website provides information about the genetic causes of Wiedemann-Rautenstrauch syndrome and how it is inherited. Visit https://ghr.nlm.nih.gov/condition/wiedemann-rautenstrauch-syndrome for more information.
  • OMIM: A comprehensive catalog of human genes and genetic disorders. This database provides in-depth information about the genetic basis of Wiedemann-Rautenstrauch syndrome, including detailed scientific articles and references. Visit https://omim.org/entry/264090 to learn more.
  • PubMed: A database of scientific articles. You can search for articles about Wiedemann-Rautenstrauch syndrome to learn about the latest research and advancements in the field. Visit https://pubmed.ncbi.nlm.nih.gov/?term=wiedemann-rautenstrauch+syndrome to explore the available articles.
  • GeneReviews: Detailed information about genetic diseases. This resource provides a comprehensive overview of Wiedemann-Rautenstrauch syndrome, including information on diagnosis, treatment, and genetic testing. Visit https://www.ncbi.nlm.nih.gov/books/NBK433601/ for more details.

These resources can help individuals and families better understand the condition, improve patient care, support scientific research, and advocate for those affected by Wiedemann-Rautenstrauch syndrome.

Genetic Testing Information

Genetic testing can provide valuable information for individuals and families affected by Wiedemann-Rautenstrauch syndrome. Testing can help identify the specific genetic causes of the condition and provide information about inheritance patterns, recurrence risks, and potential treatment options.

There are several genetic testing options available for Wiedemann-Rautenstrauch syndrome. These tests can detect abnormalities in specific genes known to be associated with the condition. The tests can be ordered through a healthcare provider or genetic counselor.

See also  CHRNA2 gene

One of the available tests is called Next Generation Sequencing (NGS), which allows for the analysis of multiple genes simultaneously. This test can help identify mutations in genes that are associated with Wiedemann-Rautenstrauch syndrome. Another test, known as Sanger sequencing, can be used to confirm specific mutations detected by NGS.

Genetic testing can also help in the diagnosis of related conditions and syndromes that may have similar features to Wiedemann-Rautenstrauch syndrome. In some cases, additional testing, such as chromosomal microarray analysis or exome sequencing, may be recommended to further evaluate the genetic cause of the condition.

It is important to note that genetic testing may not always provide conclusive results. In some cases, no genetic cause can be identified through current testing methods. It is also important to consider the limitations of current scientific knowledge and the rapidly evolving nature of genetic testing technology.

In addition to providing diagnostic information, genetic testing can also have other benefits. It can help individuals and families learn more about the condition and its expected course. It can also help connect families with advocacy organizations and support groups.

For more information about genetic testing options and resources for Wiedemann-Rautenstrauch syndrome, individuals and families can consult the following sources:

  1. Online Mendelian Inheritance in Man (OMIM): OMIM is a comprehensive catalog of genetic disorders and related information. The entry for Wiedemann-Rautenstrauch syndrome provides detailed information about the genetics of the condition, including associated genes, inheritance patterns, and scientific references.
  2. The Genetic and Rare Diseases Information Center (GARD): GARD provides information about rare diseases, including Wiedemann-Rautenstrauch syndrome. The website offers resources for patients and families, including articles about the condition and links to additional information.
  3. The National Organization for Rare Disorders (NORD): NORD is a patient advocacy organization that provides resources and support for individuals and families affected by rare diseases. The NORD website offers information about Wiedemann-Rautenstrauch syndrome, including a summary of the condition, information about support groups, and links to additional resources.

Genetic testing can play an important role in the diagnosis and management of Wiedemann-Rautenstrauch syndrome. It can provide valuable information about the genetic causes of the condition, support genetic counseling, and offer opportunities for early intervention and treatment. However, it is important to consult with healthcare providers and genetic counselors to understand the limitations, implications, and potential risks associated with genetic testing.

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center (GARD) is an initiative of the National Center for Advancing Translational Sciences (NCATS) and is a valuable resource for individuals and families seeking information on Wiedemann-Rautenstrauch syndrome, a rare genetic condition.

Wiedemann-Rautenstrauch syndrome, also known as neonatal progeroid syndrome, is a rare genetic condition that affects infants. It is a genetic disorder characterized by accelerated aging. Understanding the genetic basis of this condition can provide insights into its inheritance patterns, causes, and potential treatments.

At GARD, you can learn more about Wiedemann-Rautenstrauch syndrome, its symptoms, and its genetic and inheritance patterns. Through GARD, you can find information on the genes associated with the syndrome and the expected frequency of the condition in the population. GARD provides access to scientific articles, references, and additional resources for further learning.

GARD also offers support for patients and their families, connecting them with advocacy groups and organizations that specialize in rare diseases. They can provide information on genetic testing options and help connect individuals with healthcare professionals experienced in managing Wiedemann-Rautenstrauch syndrome.

More specifically, GARD provides information on the Wiedemann-Rautenstrauch syndrome gene, WDRPS, which is responsible for the production and synthesis of proteins. The center also offers information on other genes that may be involved in the development of this condition.

Throughout the GARD catalog, you can find descriptions of other rare genetic diseases, providing a broader understanding of the rare disease landscape. GARD is a trusted source of information for patients, families, healthcare professionals, and researchers alike.

References:

  1. Wiedemann-Rautenstrauch syndrome. OMIM. Retrieved from https://www.omim.org/entry/264090.
  2. Wiedemann-Rautenstrauch syndrome in an additional patient. PubMed. Retrieved from https://pubmed.ncbi.nlm.nih.gov/7525332/.
  3. Wiedemann-Rautenstrauch syndrome. Genetics Home Reference. Retrieved from https://ghr.nlm.nih.gov/condition/wiedemann-rautenstrauch-syndrome.
  4. Wiedemann-Rautenstrauch syndrome. Nickerson Lab Catalog of Published Genes. Retrieved from https://www.ncbi.nlm.nih.gov/research/bioninformatics/nickerson-lab/tags/wiedemann-rautenstrauch-syndrome/.

For more information about Wiedemann-Rautenstrauch syndrome, its genetic basis, and available resources, visit the Genetic and Rare Diseases Information Center.

Patient Support and Advocacy Resources

Patients with Wiedemann-Rautenstrauch syndrome, a rare genetic condition characterized by abnormal growth and development, can find support, information, and advocacy through various organizations and resources. These resources aim to provide assistance and connect patients and their families to valuable information and support networks.

Here are some patient support and advocacy resources for Wiedemann-Rautenstrauch syndrome:

  • Genetic Testing and Diagnosis: Testing for Wiedemann-Rautenstrauch syndrome can be conducted by specialized genetic testing centers. These centers utilize advanced scientific techniques to analyze an individual’s genes and identify any abnormalities or mutations associated with the condition.
  • Scientific Articles and Publications: Pubmed and other scientific databases contain articles and publications related to Wiedemann-Rautenstrauch syndrome. These articles provide valuable insights into the causes, inheritance patterns, and expected frequency of the condition.
  • Patient Support Organizations: There are patient support organizations and advocacy groups that focus on Wiedemann-Rautenstrauch syndrome. These organizations offer a platform for patients and families to share their experiences, gather information, and connect with others going through similar challenges.
  • Genetic Information Resources: Online genetic information resources like OMIM (Online Mendelian Inheritance in Man) and the Genet Test Mol Biomarkers & Cytogenet Catalog provide comprehensive information about Wiedemann-Rautenstrauch syndrome, its associated genes, and inheritance patterns.
  • Neonatal and Infant Care Centers: Neonatal and infant care centers can provide specialized care and support for infants with Wiedemann-Rautenstrauch syndrome. These centers have the expertise and resources to address the unique needs of affected infants and their families.
  • Research Centers: Research centers focused on rare genetic diseases may be conducting studies on Wiedemann-Rautenstrauch syndrome. These centers aim to synthesize existing knowledge, develop additional understanding about the condition, and potentially discover new treatment options.
See also  What is noncoding DNA

By utilizing these patient support and advocacy resources, individuals and families impacted by Wiedemann-Rautenstrauch syndrome can gain access to critical information, support networks, and specialized care to navigate their journey with this rare genetic condition.

Catalog of Genes and Diseases from OMIM

For more information about the genetic condition known as Wiedemann-Rautenstrauch syndrome, you can refer to the catalog of genes and diseases provided by OMIM (Online Mendelian Inheritance in Man). OMIM is a comprehensive database that synthesizes information about genetic disorders and their associated genes.

The syndrome, also known as neonatal progeroid syndrome, is a rare genetic condition that causes rapid aging in infants. It is caused by mutations in certain genes, such as POLR3A and POLR3B. These genes are involved in the production of polymerase proteins, which play a crucial role in DNA replication and transcription.

OMIM provides a list of genes associated with Wiedemann-Rautenstrauch syndrome, along with additional information about the inheritance pattern and clinical features of the condition. The catalog also includes references to scientific articles and resources for genetic testing and patient advocacy.

To learn more about this rare genetic syndrome and other related rare diseases, you can visit OMIM’s website or access the catalog through PubMed. The catalog provides a wealth of information about the genes and conditions, making it a valuable resource for researchers, healthcare professionals, and patients.

Here are some key points about the catalog of genes and diseases from OMIM:

  1. The OMIM catalog provides information about the genetic causes of rare diseases, including Wiedemann-Rautenstrauch syndrome.
  2. It lists the names of genes associated with the syndrome, such as POLR3A and POLR3B.
  3. The inheritance pattern of the condition is also provided in the catalog.
  4. Additional information about the clinical features of the syndrome is available.
  5. References to scientific articles and resources for genetic testing are included.
  6. OMIM’s catalog supports the synthesis of knowledge about rare genetic conditions and provides resources to support patients and their families.

In conclusion, the catalog of genes and diseases from OMIM is a valuable resource for learning more about Wiedemann-Rautenstrauch syndrome and other rare genetic conditions. It provides information about the genes associated with these conditions, their inheritance pattern, and clinical features. Researchers, healthcare professionals, and patients can access this catalog to gain a better understanding of these rare genetic diseases and access resources for support and further investigation.

Scientific Articles on PubMed

Wiedemann-Rautenstrauch syndrome is a rare condition that occurs throughout the world. It is a genetic disorder that is inherited from abnormal genes. More specifically, it is caused by mutations in the POLR3A or POLR3B gene. Infants with this condition develop an abnormal appearance, such as a large head, low hairline, and a small, pointed chin.

There are several scientific articles available on PubMed that provide information on this rare condition. These articles can help to synthesize additional information on the causes, inheritance, and associated diseases of Wiedemann-Rautenstrauch syndrome. Some of the articles are:

  • Hennekam RC, et al. Wiedemann-Rautenstrauch syndrome: new autosomal recessive disorder. Am J Med Genet. 1995 Nov 6;59(1): 14-8. PMID: 8599370.
  • Wollnik B, et al. Mutations in the accelerated region 1 of POLR3A encoding the largest subunit of RNA polymerase III cause TACH-PCIDs. Nat Genet. 2000 Jun; 24(2): 114-5. PMID: 10835637.
  • Nickerson E, et al. Mutations in the RNA Polymerase III Subunit POLR3A Cause Recessive Hypomyelinating Leukodystrophy. Am J Hum Genet. 2010 Jun 11; 86(2): 6-12. PMID: 20598274.

These articles provide valuable insights into the genetic causes of Wiedemann-Rautenstrauch syndrome and the testing methods associated with diagnosing this condition. They also offer information on other genetic diseases that may be related to this syndrome.

In addition to PubMed, there are other resources available for support and advocacy for patients with Wiedemann-Rautenstrauch syndrome. One such resource is Online Mendelian Inheritance in Man (OMIM). OMIM is a comprehensive catalog of genes and genetic disorders, including Wiedemann-Rautenstrauch syndrome.

In conclusion, there are scientific articles on PubMed that provide valuable information about Wiedemann-Rautenstrauch syndrome. These articles help to increase our understanding of the genetic causes, inheritance patterns, and associated diseases of this rare condition. They are important resources for researchers, clinicians, and patients alike.

References

  • Wiedemann-Rautenstrauch Syndrome. (n.d.). Retrieved from Genetics Home Reference: https://ghr.nlm.nih.gov/condition/wiedemann-rautenstrauch-syndrome
  • Ingraham, C. R., & O’Brien, B. M. (2002). Wiedemann-Rautenstrauch syndrome: Case report and literature review. The Cleft Palate-Craniofacial Journal, 39(1), 98-104. doi: 10.1597/1545-1569(2002)039<0098:WSRCRA>2.0.CO;2
  • Nickerson, D. A., & Maddalena, A. (2016). Wiedemann-Rautenstrauch Syndrome. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK114588/
  • Wollnik, B., & Neesen, J. (2014). Wiedemann-Rautenstrauch syndrome. Orphanet Journal of Rare Diseases, 9(1), 1. doi: 10.1186/s13023-014-0145-5
  • Kamath, B. M., & John, R. M. (2007). Wiedemann-Rautenstrauch syndrome. Indian Journal of Pediatrics, 74(8), 783-785. doi: 10.1007/s12098-007-0156-5
  • OMIM. (n.d.). WIEDEMANN-RAUTENSTRAUCH SYNDROME; WRSTS. Retrieved from Online Mendelian Inheritance in Man®: https://www.omim.org/entry/264090
  • PubMed. (n.d.). Retrieved from https://pubmed.ncbi.nlm.nih.gov/
  • Genet Test. (n.d.). Retrieved from https://www.genetests.org/
  • Genetic and Rare Diseases Information Center. (n.d.). Retrieved from https://rarediseases.info.nih.gov/diseases
  • Genetics Home Reference. (n.d.). Retrieved from https://ghr.nlm.nih.gov/
  • Genetic Testing Registry. (n.d.). Retrieved from https://www.ncbi.nlm.nih.gov/gtr/
  • Genetic Alliance UK. (n.d.). Retrieved from https://www.geneticalliance.org.uk/
  • National Society of Genetic Counselors. (n.d.). Retrieved from https://www.nsgc.org/